Valeant Pharmaceuticals

Fatal bombing in Istanbul; Valeant guides lower on a quarterly loss; Goldman, BSI scorched by 1MDB scandal.
The troubled drugmaker takes another plunge as it reduces guidance. Here’s a quick survey of the firms that are taking a bath and those that look like geniuses.
Drugmakers such as AbbVie and Valeant have been able to boost sales through direct-to-consumer advertising, but at what cost?
In the first of five stories on the battle to address skyrocketing drug prices in the U.S., <i>Institutional Investor</i> looks at how the actions of Turing Pharmaceuticals CEO Martin Shkreli set off a firestorm in Washington.